| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |